Cancer drugs get PBS green light
Nivolumab and bendamustine were added to the PBS listing this month, bringing additional treatment options for patients with melanoma and specific types of lymphoma.
Bendamustine (Ribomustin) is indicated for stage III or IV CD20 positive mantle cell lymphoma or non-Hodgkins lymphoma. In both cases treatment must be in conjunction with rituximab.
Associate Professor Stephen Opat of Monash